This compound is a Fmoc-protected beta-amino acid derivative featuring a hydroxy and a benzyl substituent on the chiral backbone. It is primarily used as a building block in solid-phase peptide synthesis, enabling the incorporation of modified amino acid residues into peptide chains.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Fmoc-D-leucine
pharmaceutical intermediate
(S)-N-Fmoc-2-Thienylalanine
pharmaceutical intermediate
N-Fmoc-S-(4-methoxybenzyl)-L-cysteine
pharmaceutical intermediate
L-Glutamic acid 1-tert-Butyl ester hydrochloride
pharmaceutical intermediate
(2R,4S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(((dimethylamino)methylene)amino)-6-oxo-1H-purin-9(6H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
pharmaceutical intermediate
Tert-butyl (5R)-5-amino-3,3-difluoropiperidine-1-carboxylate
pharmaceutical intermediate
Micafungin Impurity H
pharmaceutical intermediate
Nalpha-Fmoc-L-lysine hydrochloride
pharmaceutical intermediate
(2R,3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-hydroxy-4-phenylbutanoic acid
JZSULZSNDXGGHP-DHIUTWEWSA-N
C1=CC=C(C=C1)C[C@H]([C@H](C(=O)O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.